Pulmoner Arter Basıncı Monitorizasyonu

Khan Safi U, Zia Khan Muhammad, Mohamad Alkhouli. Trends of clinical outcomes and health care resource use in heart failure in the United States. J AmHeart Associat 2020;21:e016782.

Blecker S, PaulM, Taksler G, Ogedegbe G, Katz S. Heart failure–associated hospitalizations in the United States. J Am Coll Cardiol 2013;26:1259-1267.

Dickinson MG, Allen LA, Albert NA, et al. Remote monitoring of patients with heart failure: a white paper from the Heart Failure Society of America scientific statements committee. J Card Fail 2018;24(10):682-694.

AbrahamWT. The role of implantable hemodynamic monitors to manage heart failure. Cardiol Clin 2017;35:273-279.

Abraham WT, Adamson PB, Bourge RC, et al. CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011;377 (9766):658–666. Published correction appears in Lancet. 2012;379:412.

Alam A, Jermyn R, Mastoris I, Steinkamp L, Bhimaraj A, Sauer AJ. Ambulatory factors influencing pulmonary artery pressure waveforms and implications for clinical practice. Heart Fail Rev 2022 https://doi.org/10.1007/s10741-022-10249-3.

Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996;101(3):270-276.

Ong MK, Romano PS, Edgington S, et al. Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the better effectiveness after transition – Heart Failure (BEAT-HF) Randomized Clinical Trial. JAMA Intern Med 2016;176(3):310-318.

Abraham WT, Compton S, Haas G, et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the fluid accumulation status trial (FAST). Congest Heart Fail 2011;17(2):51-55.

Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JG. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev 2015. https://doi.org/10.1002/14651858.CD007228.pub3/full.

AbrahamWT, Perl L. Implantable hemodynamic monitoring for heart failure patients. J Am Coll Cardiol 2017;18(3):389-398.

Fa’ak F, Shabaneh B, Younis G. Direct measurement of left atrial pressure during routine Transradial catheterization. Tex Heart Inst J 2016;43(6):503-506.

Drazner MH, Velez-Martinez M, Ayers CR, et al. Relationship of right- to left-sided ventricular filling pressures in advanced heart failure: insights from the ESCAPE trial. Circ Heart Fail 2013;6(2):264-270.

Abraham WT, Adamson PB, Hasan A, et al. Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure. Am Heart J 2011;161(3):558-566.

De Rosa R, Piscione F, Schranz D, Citro R, Iesu S, Galasso G. Transcatheter implantable devices to monitoring of elevated left atrial pressures in patients with chronic heart failure. Transl Med UniSa 2018;31(17):19-24.

Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011;19;(377):658-666.

Givertz MM, Stevenson LW, Costanzo MR, et al. Pulmonary artery pressure-guided Management of Patients with Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol 2017;70(15):1875-1886.

AbrahamWT, Stevenson LW, Bourge RC, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet 2016;;387(10017):453-461.

Adamson PB, Abraham WT, Stevenson LW, et al. Pulmonary artery pressure-guided heart failure management reduces 30-day readmissions. Circ Heart Fail 2016;9(6):e002600.

Costanzo MR, Stevenson LW, Adamson PB, et al. Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressuremonitoring. JACC. Heart Fail 2016;4(5):333-344.

Shavelle DM, Desai AS, Abraham WT, et al. Lower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure: one-year outcomes from the CardioMEMS post-approval study. Circ Heart Fail 2020;13(8):e006863.

Angermann CE, Assmus B, Anker SD, et al. Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European monitoring study for heart failure (MEMS-HF). Eur J Heart Fail 2020;22(10): 1891-1901.

AbbottMedical Devices. Hemodynamic-GUIDEd Management of Heart Failure [Internet]. clinicaltrials.gov 2021 Jan.[cited 2021 Sep 16]. Report No.: NCT03387813. Available from: https://clinicaltrials.gov/ct2/show/NCT03387813).

Lindenfeld J, Zile MR, Desai AS, et al. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. The Lancet 2021;398 (10304):991-1001.

Haynes SC, Pallin R, Tong K, Henderson S, Romano PS. Understanding adherence to the CardioMEMS pulmonary artery pressure monitoring system for heart failure: a qualitative study. Heart Lung 2020;49(3):251-258.

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 2021;42(36):3599-3726.

Cowie MR, de Groote P, McKenzie S, Brett M-E, Adamson PB. CardioMEMS postmarket study investigators. Rationale and design of the CardioMEMS post-market multinational clinical study: COAST. ESC. Heart Fail 2020;7(3):865-872.

Brugts JJ, Veenis JF, Radhoe SP, et al. A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure. Neth Heart J 2020;28(1):16-26.

Salavitabar A, Bradley EA, Chisolm JL, et al. Implantable pulmonary artery pressure monitoring device in patients with palliated congenital heart disease: technical considerations and procedural outcomes. Catheter Cardiovasc Interv 2020;95(2):270-279.

DeFilippis EM, Kirtane AJ, Axsom K. Troubleshooting CardioMEMS after implantfailure to read. JAMA Cardiol 2021.[Jun 16]).

Reghunathan A, Chick JFB, Gemmete JJ, et al. Endovascular retrieval of a CardioMEMS heart failure system. Radiol Case Rep 2018;13(2):386-388.

Ijaz, S. H., Shah, S. P., & Majithia, A. (2021). Implantable devices for heart failure monitoring. Progress in Cardiovascular Diseases.

Khan Safi U, Zia Khan Muhammad, Mohamad Alkhouli. Trends of clinical outcomes and health care resource use in heart failure in the United States. J AmHeart Associat 2020;21:e016782.

Blecker S, PaulM, Taksler G, Ogedegbe G, Katz S. Heart failure–associated hospitalizations in the United States. J Am Coll Cardiol 2013;26:1259-1267.

Dickinson MG, Allen LA, Albert NA, et al. Remote monitoring of patients with heart failure: a white paper from the Heart Failure Society of America scientific statements committee. J Card Fail 2018;24(10):682-694.

AbrahamWT. The role of implantable hemodynamic monitors to manage heart failure. Cardiol Clin 2017;35:273-279.

Abraham WT, Adamson PB, Bourge RC, et al. CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011;377 (9766):658–666. Published correction appears in Lancet. 2012;379:412.

Alam A, Jermyn R, Mastoris I, Steinkamp L, Bhimaraj A, Sauer AJ. Ambulatory factors influencing pulmonary artery pressure waveforms and implications for clinical practice. Heart Fail Rev 2022 https://doi.org/10.1007/s10741-022-10249-3.

Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996;101(3):270-276.

Ong MK, Romano PS, Edgington S, et al. Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the better effectiveness after transition – Heart Failure (BEAT-HF) Randomized Clinical Trial. JAMA Intern Med 2016;176(3):310-318.

Abraham WT, Compton S, Haas G, et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the fluid accumulation status trial (FAST). Congest Heart Fail 2011;17(2):51-55.

Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JG. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev 2015. https://doi.org/10.1002/14651858.CD007228.pub3/full.

AbrahamWT, Perl L. Implantable hemodynamic monitoring for heart failure patients. J Am Coll Cardiol 2017;18(3):389-398.

Fa’ak F, Shabaneh B, Younis G. Direct measurement of left atrial pressure during routine Transradial catheterization. Tex Heart Inst J 2016;43(6):503-506.

Drazner MH, Velez-Martinez M, Ayers CR, et al. Relationship of right- to left-sided ventricular filling pressures in advanced heart failure: insights from the ESCAPE trial. Circ Heart Fail 2013;6(2):264-270.

Abraham WT, Adamson PB, Hasan A, et al. Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure. Am Heart J 2011;161(3):558-566.

De Rosa R, Piscione F, Schranz D, Citro R, Iesu S, Galasso G. Transcatheter implantable devices to monitoring of elevated left atrial pressures in patients with chronic heart failure. Transl Med UniSa 2018;31(17):19-24.

Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011;19;(377):658-666.

Givertz MM, Stevenson LW, Costanzo MR, et al. Pulmonary artery pressure-guided Management of Patients with Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol 2017;70(15):1875-1886.

AbrahamWT, Stevenson LW, Bourge RC, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet 2016;;387(10017):453-461.

Adamson PB, Abraham WT, Stevenson LW, et al. Pulmonary artery pressure-guided heart failure management reduces 30-day readmissions. Circ Heart Fail 2016;9(6):e002600.

Costanzo MR, Stevenson LW, Adamson PB, et al. Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressuremonitoring. JACC. Heart Fail 2016;4(5):333-344.

Shavelle DM, Desai AS, Abraham WT, et al. Lower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure: one-year outcomes from the CardioMEMS post-approval study. Circ Heart Fail 2020;13(8):e006863.

Angermann CE, Assmus B, Anker SD, et al. Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European monitoring study for heart failure (MEMS-HF). Eur J Heart Fail 2020;22(10): 1891-1901.

AbbottMedical Devices. Hemodynamic-GUIDEd Management of Heart Failure [Internet]. clinicaltrials.gov 2021 Jan.[cited 2021 Sep 16]. Report No.: NCT03387813. Available from: https://clinicaltrials.gov/ct2/show/NCT03387813).

Lindenfeld J, Zile MR, Desai AS, et al. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. The Lancet 2021;398 (10304):991-1001.

Haynes SC, Pallin R, Tong K, Henderson S, Romano PS. Understanding adherence to the CardioMEMS pulmonary artery pressure monitoring system for heart failure: a qualitative study. Heart Lung 2020;49(3):251-258.

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 2021;42(36):3599-3726.

Cowie MR, de Groote P, McKenzie S, Brett M-E, Adamson PB. CardioMEMS postmarket study investigators. Rationale and design of the CardioMEMS post-market multinational clinical study: COAST. ESC. Heart Fail 2020;7(3):865-872.

Brugts JJ, Veenis JF, Radhoe SP, et al. A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure. Neth Heart J 2020;28(1):16-26.

Salavitabar A, Bradley EA, Chisolm JL, et al. Implantable pulmonary artery pressure monitoring device in patients with palliated congenital heart disease: technical considerations and procedural outcomes. Catheter Cardiovasc Interv 2020;95(2):270-279.

DeFilippis EM, Kirtane AJ, Axsom K. Troubleshooting CardioMEMS after implantfailure to read. JAMA Cardiol 2021.[Jun 16]).

Reghunathan A, Chick JFB, Gemmete JJ, et al. Endovascular retrieval of a CardioMEMS heart failure system. Radiol Case Rep 2018;13(2):386-388.

Ijaz, S. H., Shah, S. P., & Majithia, A. (2021). Implantable devices for heart failure monitoring. Progress in Cardiovascular Diseases.